{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:04:04Z","timestamp":1784340244799,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmc.2019.115188","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T08:55:11Z","timestamp":1573462511000},"page":"115188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase"],"prefix":"10.1016","volume":"28","author":[{"given":"Bel\u00e9n","family":"Martinez-Gualda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Yuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathy","family":"Froeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Herdewijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirit","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.115188_b0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.str.2015.12.015","article-title":"Family-wide structural analysis of human Numb-associated protein kinases","volume":"24","author":"Sorrell","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.bmc.2019.115188_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1786","article-title":"Life of a clathrin coat: insights from clathrin and AP structures","volume":"7","author":"Edeling","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2019.115188_b0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1600-0854.2005.00346.x","article-title":"Multiple roles for cyclin G-associated kinase in clathrin-mediated sorting events","volume":"6","author":"Zhang","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.bmc.2019.115188_b0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1034\/j.1600-0854.2002.30606.x","article-title":"CK2 and GAK\/auxilin2 are major protein kinases in clathrin-coated vesicles","volume":"3","author":"Korolchuk","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.bmc.2019.115188_b0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1083\/jcb.200211080","article-title":"AP-1 binding to sorting signals and release from clathrin-coated vesicles is regulated by phosphorylation","volume":"160","author":"Ghosh","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2019.115188_b0030","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1078\/S0171-9335(04)70037-0","article-title":"Identification of the universal cofactor (auxilin 2) in clathrin coat dissociation","volume":"79","author":"Umeda","year":"2000","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.bmc.2019.115188_b0035","doi-asserted-by":"crossref","first-page":"e1002845","DOI":"10.1371\/journal.ppat.1002845","article-title":"Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly","volume":"8","author":"Neveu","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2019.115188_b0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2019.115188_b0045","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2019.115188_b0050","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets","volume":"8","author":"Neveu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.115188_b0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Infectious disease. Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bmc.2019.115188_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cmdc.201700663","article-title":"Identification and optimization of 4-anilinoquinolines as inhibitors of cyclin G associated kinase","volume":"13","author":"Asquith","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.115188_b0065","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/acs.jmedchem.8b01213","article-title":"SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK)","volume":"62","author":"Asquith","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0070","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/jm501759m","article-title":"Selective inhibitors of cyclin G associated kinase (GAK) as anti-hepatitis C agents","volume":"58","author":"Kovackova","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0075","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acs.jmedchem.8b00613","volume":"61","author":"Pu","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0080","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1039\/C5MD00229J","article-title":"Isothiazolo[4,3-b]pyridines as inhibitors of cyclin G associated kinase: synthesis, structure\u2013activity relationship studies and antiviral activity","volume":"6","author":"Li","year":"2015","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.bmc.2019.115188_b0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejmech.2018.11.065","article-title":"Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines","volume":"163","author":"Wouters","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0090","first-page":"1","article-title":"A scaffold-hopping strategy toward the identification of inhibitors of cyclin G associated kinase","volume":"13","author":"Wouters","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.115188_b0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tetlet.2006.10.124","article-title":"N-Phenylurea as an inexpensive and efficient ligand for Pd-catalyzed Heck and room-temperature Suzuki reactions","volume":"48","author":"Cui","year":"2007","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2019.115188_b0100","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1021\/jo301013c","article-title":"Preparation of highly reactive pyridine- and pyrimidine-containing diarylamine antioxidants","volume":"77","author":"Hanthorn","year":"2012","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejmech.2018.02.036","article-title":"Design, synthesis, DFT study and antifungal activity of the derivatives of pyrazolecarboxamide containing thiazole or oxazole ring","volume":"149","author":"Zhongzhong","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0110","doi-asserted-by":"crossref","first-page":"80441","DOI":"10.1039\/C5RA13094H","article-title":"MnO2 catalyzed formylation of amines and transamidation of amides under solvent-free conditions","volume":"5","author":"Subhash","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2019.115188_b0115","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.tetlet.2017.03.029","article-title":"Synthesis of bromocyclopropylpyridines via the Sandmeyer reaction","volume":"58","author":"Striela","year":"2017","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2019.115188_b0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/1087057109339207","article-title":"Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform","volume":"14","author":"Lebakken","year":"2009","journal-title":"J Biomol Screening"},{"key":"10.1016\/j.bmc.2019.115188_b0125","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"16","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2019.115188_b0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1107\/S2056989018000312","article-title":"Crystal structure of 4-(pyrazin-2-yl)morpholine","volume":"74","author":"Bandaru","year":"2018","journal-title":"Acta Crystallogr E Crystallogr Commun"},{"key":"10.1016\/j.bmc.2019.115188_b0140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/70800662","article-title":"NMR Detection of isomers arising from restricted rotation of the C-N amide bond of N-formyl-o-toluidine and N,N\u2019-bis-formyl-o-tolidine","volume":"7","author":"Quintanilla-Licea","year":"2002","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.115188_b0145","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/JVI.02424-12","article-title":"Membrane topology and function of dengue virus NS2A protein","volume":"87","author":"Xie","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.115188_b0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2011.05.001","article-title":"Development and characterization of a stable luciferase dengue virus for high-throughput screening","volume":"91","author":"Zou","year":"2011","journal-title":"Antivir Res"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619314713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619314713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:08:50Z","timestamp":1760836130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619314713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0968089619314713"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115188","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115188"}}